Investor
Relations
Spero Therapeutics is advancing next-generation immunology and inflammation medicines, bringing better options to patients who need them most.
Who we are
Company Overview
Spero Therapeutics is a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation for patients with serious diseases and major treatment gaps. The company’s lead program, SP001, is a novel, Fc-silent anti-CD40L monoclonal antibody being advanced in IgG4-related disease, with broader potential for additional immune-related conditions.
Nasdaq
SPRO
Upcoming Events
Investor Presentation
News
Latest Press Releases
SEC Filings
Board of Directors
Leadership
Committee Compensation
Documents & Charters
Analyst Coverage
Email Alerts
Stay Connected
Sign up for our investor alerts to get earnings updates, press releases, and corporate news delivered straight to your inbox.
Contact Us
FAQs
When was Spero Therapeutics Founded?
- Spero Therapeutics was founded in 2013 and went public on November 2, 2017.
On what Stock Exchange is Spero Therapeutics Traded and what is the ticker symbol?
- Spero Therapeutics is listed on the NASDAQ Global Market with a ticker symbol of SPRO.
Where is Spero Therapeutics corporate headquarters?
- Spero Therapeutics is headquartered in Cambridge, MA.
Who are the members of the Spero Therapeutics Board of Directors and Leadership Team?
- You can find information about the Board of Directors and Leadership Team on our website, here.
Does Spero Therapeutics pay a dividend? Do you have a Dividend Reinvestment Plan?
- We currently do not pay a dividend and do not offer a Dividend Reinvestment Plan.
What is Spero Therapeutics’ CUSIP?
- 84833T103.
How do I buy Spero Therapeutics stock?
- You will need to open a brokerage account.
How do I transfer stock, change the address of my shareholder account, or replace a lost stock certificate?
- Please contact your broker if you own your shares through a broker, or if you beneficially own your shares, please contact our transfer agent.
Who is Spero Therapeutics’ transfer agent?
- Computershare is Spero’s transfer agent.
Who is Spero Therapeutics’ independent auditor?
- Our independent auditor is PwC.
Where is Spero Therapeutics incorporated?
- Spero Therapeutics is incorporated in Delaware, United States.
How do I contact investor relations?
- You can reach out to investor relations at IR@sperotherapeutics.com.
How do I get added to Spero Therapeutics’ email list?
- To subscribe to Spero Therapeutics’ email list, sign up here.
Where can I find all the SEC filings for Spero Therapeutics? Where can I download and view quarterly and annual reports?
- All SEC filings can be found and downloaded here.